Tianjin Tianyao Pharmaceuticals Co., Ltd. Class ASSE: 600488

"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining Drug Registration Certificate for Ropivacaine Hydrochloride Injection by Subsidiary

Sep 30, 2026 · Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Drug Registration Certificate for Ropivacaine Hydrochloride Injection by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A

"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Indicative Announcement on Listing and Transfer of 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd. by Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.Sep 25
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 1st Meeting of the 10th Board of DirectorsSep 19
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin JurisdictionSep 4
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Provision for Impairment and Write-off of Assets for the First Half of 2026Aug 26

All Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A news releases